ChronoScale Corporation Common Stock (NASDAQ:CHRN) Announces Quarterly Earnings Results

ChronoScale Corporation Common Stock (NASDAQ:CHRN) released its earnings results on Wednesday. The company reported ($0.29) earnings per share for the quarter, FiscalAI reports. The firm had revenue of $41.48 million during the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%.

ChronoScale Corporation Common Stock Stock Up 7.9%

Shares of CHRN stock traded up $1.17 on Thursday, reaching $16.05. 317,798 shares of the stock were exchanged, compared to its average volume of 227,913. ChronoScale Corporation Common Stock has a twelve month low of $3.50 and a twelve month high of $30.00. The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $2.34 billion, a price-to-earnings ratio of -2.98 and a beta of 0.98. The business’s 50 day moving average price is $19.98 and its 200 day moving average price is $18.15.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Weiss Ratings raised shares of ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, October 9th. Northland Securities started coverage on ChronoScale Corporation Common Stock in a research report on Friday, September 18th. They issued an “outperform” rating and a $32.00 price target on the stock. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, ChronoScale Corporation Common Stock has a consensus rating of “Hold” and an average target price of $19.00.

Institutional Investors Weigh In On ChronoScale Corporation Common Stock

An institutional investor recently raised its position in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc increased its holdings in shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) by 104.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,338 shares of the company’s stock after purchasing an additional 1,195 shares during the quarter. Roble Belko & Company Inc owned approximately 0.07% of ChronoScale Corporation Common Stock worth $25,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.